The systemic nature and widespread prevalence of MASH have led to significant economic burdens, with costs reaching $222.6 billion in the USA in 2017 and up to 19.5 billion in Europe, encompassing both direct (medical care, diagnostic procedures, drugs, hospitalization) and indirect costs (loss of productivity, reduced quality of life, morbidity, and mortality) [11, 12]
Similar findings emerged from the STEP weight management trials, where heart rate elevations of comparable magnitude were documented
Your DermaVue doctor will advise on the most appropriate option based on quality and your clinical needs
For example, they might recommend adjustments to your diet or exercise routine to help stabilize your menstrual cycle
Pair carbohydrates with protein and fat to maintain stable blood sugar levels
Semaglutide is a great option for patients who: Are facing challenges in shedding weight with diet and exercise alone Are looking to achieve sizeable weight loss, stabilize their blood sugar, or both Are seeking out treatments with cardiovascular benefits Are ready and able to adhere to the treatment plan, which involves weekly injections Patients should prioritize consultations with a healthcare professional specializing in weight management to evaluate their unique circumstances and determine if Semaglutide is right for them
